| Log in

Cipla acquires majority stake in Sri Lankan drug distributor for $14M

17 June, 2014

Indian pharma major Cipla Ltd has acquired 60 per cent stake in a Sri Lanka-based company for $14 million which would market its products in the country, it announced in the stock exchange on Tuesday. The name of the target company was not disclosed.

According to the announcement, the company entered this transaction through its wholly owned subsidiary – Cipla (Mauritius) Limited.

As part of its strategy to enhance scale of manufacturing and products, the company has been looking at various strategies of acquisitions and investments.

Last year the company acquired its distribution partner in South Africa – Cipla Medpro South Africa – Ltd for around $512 million. This was company’s first acquisition in three years. In 2010, the company acquired stake in Meditab Specialities Pvt Ltd, Mab Pharm and a drug formulation facility in Sikkim.

Apart from acquisition of other players, Cipla has also investing in various companies through its investment arm Cipla New Ventures.

(Edited by Joby Puthuparampil Johnson)


Leave Your Comment
Cipla signs pact to invest $37M for manufacturing unit in Iran with 75% stake

Cipla signs pact to invest $37M for manufacturing unit in Iran with 75% stake

Anuradha Verma 3 years ago
Mumbai-based drug maker Cipla Limited has inked a definitive agreement with its...
Cipla forms JV with existing partners Cooper Pharma and PHI in Morocco

Cipla forms JV with existing partners Cooper Pharma and PHI in Morocco

Jasleen Kaur Batra 3 years ago
Mumbai-based drug maker Cipla Limited has entered into a joint venture agreement...
Cipla to buy Brazilian drug distributor Duomed

Cipla to buy Brazilian drug distributor Duomed

Jasleen Kaur Batra 3 years ago
Mumbai-based drugmaker Cipla Ltd has inked a deal to buy Duomed Produtos...
No Comments

Cipla acquires majority stake in Sri Lankan drug distributor for $14M

Powered by WordPress.com VIP